Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial.
Authors: Mueller L; Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.; Department of Clinical Research, University of Basel, Basel, Switzerland., Santos de Jesus J; Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.; Department of Clinical Research, University of Basel, Basel, Switzerland., Schmid Y; Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.; Department of Clinical Research, University of Basel, Basel, Switzerland., Müller F; Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.; Department of Clinical Research, University of Basel, Basel, Switzerland.; University Psychiatric Clinic Basel, Basel, Switzerland., Becker A; Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.; Department of Clinical Research, University of Basel, Basel, Switzerland., Klaiber A; Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.; Department of Clinical Research, University of Basel, Basel, Switzerland., Straumann I; Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.; Department of Clinical Research, University of Basel, Basel, Switzerland., Luethi D; Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.; Department of Clinical Research, University of Basel, Basel, Switzerland.; Department of Biomedicine, University of Basel, Basel, Switzerland., Haijen ECHM; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands., Hurks PPM; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands., Kuypers KPC; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands., Liechti ME; Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.; Department of Clinical Research, University of Basel, Basel, Switzerland.; Department of Biomedicine, University of Basel, Basel, Switzerland.
Source: JAMA psychiatry [JAMA Psychiatry] 2025 Jun 01; Vol. 82 (6), pp. 555-562.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print Cited Medium: Internet ISSN: 2168-6238 (Electronic) Linking ISSN: 2168622X NLM ISO Abbreviation: JAMA Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2168-6238
DOI:10.1001/jamapsychiatry.2025.0044